SCHEMBL29296649

SCHEMBL29296649

CC(C)C(=O)CSc1ccccc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 7/20 0.51
HSD17B10 Q99714 3/20 0.51
RAB9A P51151 2/20 0.51
GAA P10253 1/20 0.51
ALDH1A1 P00352 4/20 0.45
CYP1A2 P05177 2/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.42
HPGD P15428 2/20 0.41
HTT P42858 2/20 0.41
BACE1 P56817 1/20 0.40
NPC1 O15118 2/20 0.38
IDO1 P14902 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL806076 0.80 POLB (0.55) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL29812491 0.78 CYP1A2 (0.61) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL1157659 0.78 CYP1A2 (0.61) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL29297658 0.78 RAB9A (0.57) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL23877213 0.77 POLB (0.53) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL22850297 0.76 POLB (0.36) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL714953 0.74 FFAR1 (0.61) POLBHSD17B10RAB9AALDH1A1SMN1; SMN2
SCHEMBL6271484 0.74 RAB9A (0.65) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL11868155 0.72 ALDH1A1 (0.52) POLBHSD17B10RAB9AGAAALDH1A1
SCHEMBL20819196 0.72 POLB (0.51) POLBHSD17B10RAB9AGAAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228495-A1 Tricyclic Inhibitors of Influenza Virus Endonuclease STANFORD RES INST INT (US) 2024-07-11 US disclosed
US-20240228495-A1 Tricyclic Inhibitors of Influenza Virus Endonuclease STANFORD RES INST INT (US) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228495-A1 Tricyclic Inhibitors of Influenza Virus Endonuclease RNASEH1, RNASEL, DNASE1 POLB 116/4885HSD17B10 1977/4885RAB9A 3172/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.